[HTML][HTML] Healing from Within: How Gut Microbiota Predicts IBD Treatment Success—A Systematic Review
L Alexandrescu, AD Nicoara, DE Tofolean… - International Journal of …, 2024 - mdpi.com
Recent research indicates that the microbiome has a significant impact on the progression of
inflammatory bowel disease (IBD) and that creating therapies that change its composition …
inflammatory bowel disease (IBD) and that creating therapies that change its composition …
The networked interaction between probiotics and intestine in health and disease: a promising success story
M Skoufou, C Tsigalou, S Vradelis, E Bezirtzoglou - Microorganisms, 2024 - mdpi.com
Probiotics are known to promote human health either precautionary in healthy individuals or
therapeutically in patients suffering from certain ailments. Although this knowledge was …
therapeutically in patients suffering from certain ailments. Although this knowledge was …
Probiotics: Health benefits, food application, and colonization in the human gastrointestinal tract
LYJ Lau, SY Quek - Food Bioengineering, 2024 - Wiley Online Library
Probiotics have become increasingly popular over the past two decades due to the
continuously expanding scientific evidence indicating their beneficial effects on human …
continuously expanding scientific evidence indicating their beneficial effects on human …
Bacteria-based drug delivery for treating non-oncological diseases
Bacteria inhabit all over the human body, especially the skin, gastrointestinal tract,
respiratory tract, urogenital tract, as well as specific lesion sites, such as wound and tumor …
respiratory tract, urogenital tract, as well as specific lesion sites, such as wound and tumor …
An integrative multi-omic analysis defines gut microbiota, mycobiota, and metabolic fingerprints in ulcerative colitis patients
Background Ulcerative colitis (UC) is a multifactorial chronic inflammatory bowel disease
(IBD) that affects the large intestine with superficial mucosal inflammation. A dysbiotic gut …
(IBD) that affects the large intestine with superficial mucosal inflammation. A dysbiotic gut …
Advances and optimization strategies in bacteriophage therapy for treating inflammatory bowel disease
Y Li, X Li, H Duan, K Yang, J Ye - Frontiers in Immunology, 2024 - frontiersin.org
In the advancement of Inflammatory Bowel Disease (IBD) treatment, existing therapeutic
methods exhibit limitations; they do not offer a complete cure for IBD and can trigger adverse …
methods exhibit limitations; they do not offer a complete cure for IBD and can trigger adverse …
Intestinal Fibrogenesis in Inflammatory Bowel Diseases: Exploring the Potential Role of Gut Microbiota Metabolites as Modulators
S Cicchinelli, S Gemma, G Pignataro, A Piccioni… - Pharmaceuticals, 2024 - mdpi.com
Fibrosis, sustained by the transformation of intestinal epithelial cells into fibroblasts
(epithelial-to-mesenchymal transition, EMT), has been extensively studied in recent …
(epithelial-to-mesenchymal transition, EMT), has been extensively studied in recent …
Enhanced anti-inflammatory activity of chlorogenic acid via folic acid-TPGS-modified liposomes encapsulation: characterization and In vivo evaluation on colitis mice
Q Li, J Yan, Z Zhou, X Geng, J Xiong - Frontiers in Pharmacology, 2024 - frontiersin.org
Introduction Chlorogenic acid (CGA) has been identified to possess salient anti-
inflammatory, antioxidant, and anticancer attributes. However, its application is limited by its …
inflammatory, antioxidant, and anticancer attributes. However, its application is limited by its …
Prospective therapeutic targets and recent advancements in the treatment of inflammatory bowel disease
A Sinha, S Roy - Immunopharmacology and Immunotoxicology, 2024 - Taylor & Francis
Abstract Objective Inflammatory Bowel Disease (IBD) poses a persistent challenge in the
realm of gastroenterology, necessitating continual exploration of innovative treatment …
realm of gastroenterology, necessitating continual exploration of innovative treatment …
Exploring the Potential of Humoral Immune Response to Commensal Bifidobacterium as a Biomarker for Human Health, including Both Malignant and Non-Malignant …
K Itoh, S Matsueda - Biomedicines, 2024 - mdpi.com
In this comprehensive review, we explore the pivotal role of commensal Bifidobacterium (c-
BIF) as potent non-self-antigens through antigenic mimicry, along with exploring the …
BIF) as potent non-self-antigens through antigenic mimicry, along with exploring the …